CVE-2024-10198
Published: 21 October 2024
Summary
CVE-2024-10198 is a medium-severity Cross-site Scripting (CWE-79) vulnerability in Code-Projects Pharmacy Management. Its CVSS base score is 5.1 (Medium).
Operationally, ranked at the 34.2th percentile by exploit likelihood (below the median); it is not currently listed in the CISA KEV catalog; a public proof-of-concept is referenced.
EU & UK References
- 🇪🇺 ENISA EUVD: EUVD-2024-32976
Vulnerability details
A vulnerability was found in code-projects Pharmacy Management System 1.0. It has been declared as problematic. Affected by this vulnerability is an unknown functionality of the file /manage_customer.php of the component Manage Customer Page. The manipulation of the argument suppliers_name/address…
more
leads to cross site scripting. The attack can be launched remotely. The exploit has been disclosed to the public and may be used. The initial researcher advisory mentions contradicting files to be affected. Other parameters might be affected as well.
- CWE(s)
Related Threats
No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.
Affected Assets
Mitigating Controls
Likely Mitigating Controls AI
Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.
Penetration testing submits XSS payloads to web applications, detecting cross-site scripting flaws for subsequent remediation.
Validates web inputs to reject script-related content that could produce XSS.
Output validation against expected content can reject or sanitize script content in generated web pages, reducing XSS exploitability.